246 related articles for article (PubMed ID: 29321510)
81. MicroRNAs in idiopathic pulmonary fibrosis.
Pandit KV; Milosevic J; Kaminski N
Transl Res; 2011 Apr; 157(4):191-9. PubMed ID: 21420029
[TBL] [Abstract][Full Text] [Related]
82. Lung fibroblasts express a miR-19a-19b-20a sub-cluster to suppress TGF-β-associated fibroblast activation in murine pulmonary fibrosis.
Souma K; Shichino S; Hashimoto S; Ueha S; Tsukui T; Nakajima T; Suzuki HI; Shand FHW; Inagaki Y; Nagase T; Matsushima K
Sci Rep; 2018 Nov; 8(1):16642. PubMed ID: 30413725
[TBL] [Abstract][Full Text] [Related]
83. CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins.
Tran-Nguyen TK; Xue J; Feghali-Bostwick C; Sciurba FC; Kass DJ; Duncan SR
Am J Respir Cell Mol Biol; 2020 Aug; 63(2):255-265. PubMed ID: 32320626
[TBL] [Abstract][Full Text] [Related]
84. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.
Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z
Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795
[TBL] [Abstract][Full Text] [Related]
85. IPF-Fibroblast Erk1/2 Activity Is Independent from microRNA Cluster 17-92 but Can Be Inhibited by Treprostinil through DUSP1.
Blumer S; Fang L; Chen WC; Khan P; Hostettler K; Tamm M; Roth M; Lambers C
Cells; 2021 Oct; 10(11):. PubMed ID: 34831059
[TBL] [Abstract][Full Text] [Related]
86. 3'5-Dimaleamylbenzoic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
González-García K; López-Martínez A; Velázquez-Enríquez JM; Zertuche-Martínez C; Carrasco-Torres G; Sánchez-Navarro LM; Villa-Treviño S; Baltiérrez-Hoyos R; Vásquez-Garzón VR
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887292
[TBL] [Abstract][Full Text] [Related]
87. The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis.
Kim HS; Moon SJ; Lee SE; Hwang GW; Yoo HJ; Song JW
Exp Mol Med; 2021 May; 53(5):864-874. PubMed ID: 33990688
[TBL] [Abstract][Full Text] [Related]
88. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
[TBL] [Abstract][Full Text] [Related]
89. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
[TBL] [Abstract][Full Text] [Related]
90. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
[TBL] [Abstract][Full Text] [Related]
91. Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis.
Jaffar J; Glaspole I; Symons K; Westall G
Biomed Pharmacother; 2021 Jun; 138():111471. PubMed ID: 33730605
[TBL] [Abstract][Full Text] [Related]
92. LncRNA PFAR contributes to fibrogenesis in lung fibroblasts through competitively binding to miR-15a.
Sun J; Su W; Zhao X; Shan T; Jin T; Guo Y; Li C; Li R; Zhou Y; Shan H; Sun X; Liang H
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31273058
[TBL] [Abstract][Full Text] [Related]
93. HYAL1 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits HFL-1 Fibroblast Proliferation When Upregulated.
Leng D; Huang X; Yi J; Zhao H; Zhang Y
Biomed Res Int; 2020; 2020():3659451. PubMed ID: 32258117
[TBL] [Abstract][Full Text] [Related]
94. Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue.
Xu X; Wan X; Geng J; Li F; Wang C; Dai H
Int J Mol Med; 2013 Aug; 32(2):430-8. PubMed ID: 23760654
[TBL] [Abstract][Full Text] [Related]
95. Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6.
Höhne K; Wagenknecht A; Maier C; Engelhard P; Goldmann T; Schließmann SJ; Plönes T; Trepel M; Eibel H; Müller-Quernheim J; Zissel G
Cells; 2024 Jan; 13(3):. PubMed ID: 38334630
[TBL] [Abstract][Full Text] [Related]
96. TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation.
Wu M; Wang Z; Shi X; Zan D; Chen H; Yang S; Ding F; Yang L; Tan P; Ma RZ; Wang J; Ma L; Ma Y; Jin J
Respir Res; 2023 Sep; 24(1):222. PubMed ID: 37710230
[TBL] [Abstract][Full Text] [Related]
97. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
Ghanem M; Archer G; Crestani B; Mailleux AA
Pharmacol Ther; 2024 Jul; 259():108669. PubMed ID: 38795981
[TBL] [Abstract][Full Text] [Related]
98. Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice.
Habiel DM; Espindola MS; Coelho AL; Hogaboam CM
Am J Pathol; 2018 Apr; 188(4):891-903. PubMed ID: 29378172
[TBL] [Abstract][Full Text] [Related]
99. Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors.
Campiani G; Cavella C; Osko JD; Brindisi M; Relitti N; Brogi S; Saraswati AP; Federico S; Chemi G; Maramai S; Carullo G; Jaeger B; Carleo A; Benedetti R; Sarno F; Lamponi S; Rottoli P; Bargagli E; Bertucci C; Tedesco D; Herp D; Senger J; Ruberti G; Saccoccia F; Saponara S; Gorelli B; Valoti M; Kennedy B; Sundaramurthi H; Butini S; Jung M; Roach KM; Altucci L; Bradding P; Christianson DW; Gemma S; Prasse A
J Med Chem; 2021 Jul; 64(14):9960-9988. PubMed ID: 34251197
[TBL] [Abstract][Full Text] [Related]
100. Pharmacological inhibition of MDM4 alleviates pulmonary fibrosis.
Mei Q; Yang Z; Xiang Z; Zuo H; Zhou Z; Dong X; Zhang L; Song W; Wang Y; Hu Q; Zhou Y; Qu J
Theranostics; 2023; 13(9):2787-2799. PubMed ID: 37284444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
